Table 1.
The summary of the reported research involving types of NMs and DDS, along with therapeutic molecules, polymers and the obtained result
| Types of NM | Types of DDS | Therapeutic agent | Polymer | Result | Ref. |
|---|---|---|---|---|---|
| Gold NPs | Nanocomposite (Gold Nanoclusters) | AZD8055 | Albumin | Significant cellular toxicity with decreasing the tumor surface | [80] |
| Nanocomposite | Chalcones | - | Antitumor activity through the generation of ROS | [81] | |
| NPs | Paclitaxel | - | Antimelanoma activity through the generation of ROS and induction of apoptosis | [83] | |
| Nanocomposite (Gold nanorods) | - | Gum arabic | Reduced primary tumour growth by 45 % and reduced melanoma metastasis | [9] | |
| Gold-nanoshell | Doxorubicin | Antibody and PEG | Expression of significantly higher level of PD-L1. Precise targeting and delivery of drugs to melanoma cells | [84] | |
| Theranostic nanoprobe | - | p-MBA Anti-MUC18 single chain antibody (scFy) | In vivo melanoma site tracing, biodistribution study and targeted treatment | [86] | |
| Nanocomposite | - | HA and oleic acid | More effective against non-metastatic melanoma or other superficial tumours | [87] | |
| Nanocomposite | - | Folic acid | Decreased viability of melanoma cells and decrease in side effects. | [88] | |
| Gold NPs and TiO2 nanorods | Nanocomposite | - | - | Reduction of cell viability to less than 1 % | [89] |
| Au-MnO2 nano-composite | Nanocomposite | - | - | Cytotoxicity of C540 cell lines in a dose-dependent manner | [90] |
| Silver NPs | Nanocomposite hydrogel | Chitosan and starch | A dose-dependent decrease in % of cell viability | [98] | |
| Organometallic Nanocomposite | Pheophorbide-a(Ph-a) | Effective suppression of tumour growth in vivo | [99] | ||
| Nanohybrid bio-hydrogel | CMC and poly(acrylic acid-co-maleic acid | Reduced the viability of melanoma cells in a dose and time-dependent manner by the generation of ROS and cell death | [100] | ||
| Nanohybrid hydrogel | Doxorubicin | CMC | Killing of melanoma cells synergistically and antibacterial effect | [101] | |
| Nanocomposite | Cisplatin | PVP | Induction of both apoptosis and necrosis | [102] | |
| Silver NPs and platinum NPs | Nanocomposite | - | - | Selective cytotoxicity of melanoma cells through enhanced permeability and retention in these cells | [2] |
| CTNPs | Ferroptosis-activating vaccine | - | OVA and melanoma B16-OVA membrane | Trigger ferroptosis and induction of immunogenic cell death through strong immune response in vivo | [110] |
| CuO2NPs | Nanocomposite | - | PVP | Transform endogenous H2O2 into highly toxic OH and glutathione (GSH)-scavenging for ROS-induced tumour cell death | [21] |
| Pt-NPs | Nanocomposite | Doxorubicin | PEG | inhibition of cancer cell proliferation and induced apoptosis of cancer cells | [113] |
| Pt mesoporous NPs (Pt-MNPs) | NPs | - | --- | Low melanoma cell viability (L1 %) due to significant generation of ROS | [119] |
| Silica NPs | Nanocomplex | Curcumin | - | Higher cancerous cell death due to the formation ROS | [125] |
| Mesoporous silica NPs | Nanocomplex | Verteporfin | - | Selectively reduced cancer cell proliferation | [28] |
| Mesoporous-silica NPs | NPs | - | - | Selective tumour growth inhibition due to higher amount ROS formation | [126] |
| PEGylated Silica NPs | Core-shell NPs | - | PEG and αvβ3-integrin melanoma targeting peptides | Precise targeting and induced ferroptosis in starved cancer cells | [127] |
| Mesoporous silica NPs | 2D core-shell nanosystem with silica layer | Cisplatin | - | Synergistic pyroptosis and hyperthermia of melanoma carcinoma | [129] |
| MCM | NPs | Quercetin | - | Improves stability of quercetin and enhanced quercetin penetration across skin | [130] |
| Gold NPs and mesoporous silica NPs | Gold nanoshell on rod-like mesoporous silica NPs | - | - | Effective penetration into melanoma tissues and potential ablation of malignant melanoma cells | [128] |
| TiO2 NPs | Nanocomposite | Curcumin | - | DNA damage, apoptosis and stopping the cells at the G2/M phase | [135] |
| Iron NPs | MPN nanocomposite | Cabazitaxel | Chitosan | Higher retention time in tumor tissues and thereby significant reduction of tumor growth | [144] |
| MPN nanocomposite | Gallic acid | Hyaluronic acid | Synergistic therapy (PDT and CDT) against melanoma due to the generation of ROS | [145] | |
| Nanocomposite - hydrogel | Polydopamine-Fe(III)-doxorubicin NP | Alginate | Significant inhibition of proliferation and migration of melanoma cells due to hyperthermia. It also induces skin generation. | [146] | |
| SWCNTs | Nanovector | Doxorubicin | - | Ceased the tumour growth without producing systemic side effects | [154] |
| MWCNTs | Nanocomposite | Polypyrrole | - | Concentration-dependent cytotoxicity with a cell viability of 8.9% due to hyperthermia | [155] |
| rGO | Nanocomposite hydrogel | 5-fluorouracil | CMARX | Significant anticancer activities and antibacterial activities | [167] |
| nGO | Nanocomposite sheets | Dacarbazine | Chitosan oligosaccharide and CD47 antibody | Simultaneous induction of apoptosis through the mitochondria apoptosis pathway | [168] |
| Graphene | Nanotransporter | Fluorescence protein expression plasmid DNA (pDNA) | Magnetic NPs and PEI | Efficient delivery of pDNA into the melanoma cells through condensation | [169] |
| Nano-diamonds | NPs | - | - | Potential reduction of the metastasis through inhibition of the migration of Hela cells | [170] |
| Polymeric nanocapsules | NPs | Curcumin | PBA and AEMA | Selectively killed more than 90% of human malignant melanoma cells | [183] |
| Hybrid NPs | Vitamin D3 | PLGA and hydrogenated soy phosphatidylcholine, cholesterol and 1,2-disteroyl-sn-glycero-3-phospha ethanolamine-N[succinyl (PEG)-2000 | Target B16 melanoma cells efficiently | [184] | |
| NPs | Celecoxib and afuresertib | PLGA, PEG and targeting peptide IL4RPep-1 | Enhancement of apoptosis and regulation of M2 macrophages in tumor cells to reprogram M1 macrophages | [185] | |
| Dendrimers | Nanoconjugates | Temozolomide | PAMAM-PEG-GE11-HA | Targeting towards A375 human melanoma cell | [189] |
| Core-shell nanomicelles | Dabrafenib and vemurafenib | G2 PAMAM head and C18 aliphatic chains | Release of drugs enhanced at acidic pH 5.0 and enhanced antimelanoma response | [7] | |
| Polymeric micelles | Nanomicelleles | Doxorubicin | mPEG-b-PLAGA and IR-768 | Triggered synergistic anticancer effect in melanoma cells | [192] |
| Nanogel | Nanogel | GOX | FBMA and OEGMA (poly(FBMA-co-OEGMA) | Improved antimelanoma efficacy without systemic toxicity due to the confinement of GOX to only tumour region | [197] |
| Thermosensitive nano-hydrogel | PP-NPs containing deferasirox | Agarose and TMPO-oxidized lignocellulose | Dose-dependent cytotoxicity | [198] | |
| Liposomes | Liposomes + Vaccines | Celecoxib | Dendritic cell vaccines pulsed with gp100 peptide | Tumour growth inhibition and overall survival | [207] |
| Chitosan coated liposomes | Indocyanine green | Chitosan | Higher cellular uptake and photocytotoxicity of melanoma cells due to high skin permeability | [208] | |
| HA-coated liposomes | Dacarbazine and eugenol | HA | Higher cytotoxicity against melanoma cells along with significantly higher inhibition of cell migration and proliferation | [209] | |
| AS1411 aptamer functionalized liposomes | 5-fluorouracil | AS1411 aptamer | Higher efficiency in terms of in vitro cell viability, apoptotic effects and targeting capability | [210] | |
| - | - | - | Tool to enrich the blood proteomic analysis | [211] | |
| Niosomes | - | 5-fluorouracil | - | Improved the stability and enhanced the skin permeation ability | [214] |
| Ethosomes and transferosome | - | Sulforaphane | - | Higher skin permeability and improved anticancer activity due to antiproliferative activity | [215] |
| SLNs | - | 4NC and DETC | Beeswax | Higher cytotoxicity reduces cell viability | [11] |
| Exosomes | Ir-Fe@Exo | - | Ir-Fe NPs camouflage with melanoma exosomes | Full eradication of melanoma tumour with single treatment and prevent the metastasis | [229] |
| Gene therapy | Nanoworm | siRNA (siSuvivin) | Nanoerythrocytes | Protects siRNA and superior anti-melanoma effect | [232] |